Itai A. Bab

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2.

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2.

Journal: eLife

Published: December 16, 2020

HU-671, a Novel Oleoyl Serine Derivative, Exhibits Enhanced Efficacy in Reversing Ovariectomy-Induced Osteoporosis and Bone Marrow Adiposity.

HU-671, a Novel Oleoyl Serine Derivative, Exhibits Enhanced Efficacy in Reversing Ovariectomy-Induced Osteoporosis and Bone Marrow Adiposity.

Journal: Molecules (Basel, Switzerland)

Published: August 30, 2019

Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity.

Magel2 Modulates Bone Remodeling and Mass in Prader-Willi Syndrome by Affecting Oleoyl Serine Levels and Activity.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: March 06, 2018

Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor.

Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor.

Journal: Bone

Published: May 12, 2017

Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes.

Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes.

Journal: Journal of cellular physiology

Published: March 06, 2017

Behavioural changes induced by a conditional disruption of bone formation.

Behavioural changes induced by a conditional disruption of bone formation.

Journal: Journal of basic and clinical physiology and pharmacology

Published: December 13, 2015

A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice.

A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice.

Journal: Nature medicine

Published: July 27, 2015

CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.

CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 01, 2015

CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol.

CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol.

Journal: Annals of the New York Academy of Sciences

Published: January 10, 2015

Endocannabinoid signaling at the periphery: 50 years after THC.

Endocannabinoid signaling at the periphery: 50 years after THC.

Journal: Trends in pharmacological sciences

Published: December 18, 2014

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.

The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.

Journal: eLife

Published: December 07, 2014

Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.

Cannabidiol, a Major Non-Psychotropic Cannabis Constituent Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: June 04, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026